Medigen Vaccine (Taiwan) Price on April 7, 2023
6547 Stock | TWD 38.90 0.25 0.64% |
If you're considering investing in Medigen Stock, it is important to understand the factors that can impact its price. As of today, the current price of Medigen Vaccine stands at 38.90, as last reported on the 29th of November, with the highest price reaching 39.35 and the lowest price hitting 38.20 during the day. Medigen Vaccine Biologics has Sharpe Ratio of -0.26, which conveys that the firm had a -0.26% return per unit of risk over the last 3 months. Medigen Vaccine exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medigen Vaccine's Risk Adjusted Performance of (0.16), standard deviation of 1.46, and Mean Deviation of 1.15 to check out the risk estimate we provide.
Medigen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Medigen |
Sharpe Ratio = -0.2565
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 6547 |
Estimated Market Risk
1.48 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medigen Vaccine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medigen Vaccine by adding Medigen Vaccine to a well-diversified portfolio.
Medigen Vaccine Valuation on April 7, 2023
It is possible to determine the worth of Medigen Vaccine on a given historical date. On April 7, 2023 Medigen was worth 58.7 at the beginning of the trading date compared to the closed value of 59.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Medigen Vaccine stock. Still, in general, we apply an absolute valuation method to find Medigen Vaccine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medigen Vaccine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Medigen Vaccine's related companies.
Open | High | Low | Close | Volume | |
58.30 | 59.00 | 58.10 | 58.50 | 1,836,000 | |
04/07/2023 | 58.70 | 60.70 | 58.30 | 59.30 | 3,267,388 |
59.90 | 59.90 | 58.10 | 58.10 | 1,642,796 |
Backtest Medigen Vaccine | | | Medigen Vaccine History | | | Medigen Vaccine Valuation | Previous | Next |
Medigen Vaccine Trading Date Momentum on April 7, 2023
On April 10 2023 Medigen Vaccine Biologics was traded for 58.10 at the closing time. The highest price during the trading period was 59.90 and the lowest recorded bid was listed for 58.10 . The volume for the day was 1.6 M. This history from April 10, 2023 contributed to the next trading day price decline. The daily price change to the next closing price was 2.02% . The trading delta at closing time to the current price is 20.57% . |
Medigen Vaccine Biologics Fundamentals Correlations and Trends
By evaluating Medigen Vaccine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Medigen Vaccine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Medigen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Medigen Vaccine Stock history
Medigen Vaccine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medigen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medigen Vaccine Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medigen Vaccine stock prices may prove useful in developing a viable investing in Medigen Vaccine
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp. MEDIGEN VACCINE operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
Medigen Vaccine Stock Technical Analysis
Medigen Vaccine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Medigen Vaccine Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Medigen Vaccine Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan OTC Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Medigen Vaccine November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Medigen Vaccine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medigen Vaccine shares will generate the highest return on investment. By undertsting and applying Medigen Vaccine stock market strength indicators, traders can identify Medigen Vaccine Biologics entry and exit signals to maximize returns
Medigen Vaccine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Medigen Vaccine's price direction in advance. Along with the technical and fundamental analysis of Medigen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medigen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.16) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (0.55) | |||
Treynor Ratio | (1.50) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Medigen Stock Analysis
When running Medigen Vaccine's price analysis, check to measure Medigen Vaccine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Vaccine is operating at the current time. Most of Medigen Vaccine's value examination focuses on studying past and present price action to predict the probability of Medigen Vaccine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Vaccine's price. Additionally, you may evaluate how the addition of Medigen Vaccine to your portfolios can decrease your overall portfolio volatility.